Dr. Paul Sorajja is an interventional cardiologist at Banner Health in Phoenix, AZ.  He received his M.D. from Mayo Medical School, and completed his Internal Medicine Residency and Cardiology Fellowship at the Mayo Graduate School of Medicine in Rochester, MN.  Dr. Sorajja joined the Mayo Clinic staff in 2006, achieving the rank of Professor of Medicine in 2012. In 2013, Dr. Sorajja joined the Minneapolis Heart Institute where he served as Director for the Center of Valve and Structural Heart Disease, and as an Endowed Chair for Valve Science in the Minneapolis Heart Institute Fondation.  In 2025, Dr. Sorajja joined Banner Health, where he is the Lentsch Family Chair for Valve and Structural Heart, the Director of Interventional Cardiology at Banner University Medical Center - Phoenix, and the Associate Director for the Banner Heart Institute. Dr. Sorajja has published over 500 peer-reviewed papers and book chapters over his career.  He is known especially for performing many first-in-human therapies in valve disease, including the first TriClip (2017), MitraClip laceration and TMVR (2018), dedicated TMVR in severe MAC (2016), vDyne (2021), MitraClip for HCM (2016), among many others.